NCT06675656View on ClinicalTrials.gov

Predictive Role of Microbiome in Patients With Urothelial Carcinoma

Not yet recruitingOBSERVATIONAL
Enrollment

420

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2035

Conditions
Urinary Bladder Cancer
Interventions
OTHER

DNA extraction from urine, stool and biopsy. Isolation of serum and PBMC from peripheral blood.

DNA extraction from urine, stool and biopsy for microbiome analysis. Isolation of peripheral blood mononuclear cells from peripheral blood for immunophenotypic analysis, and isolation of serum for analysis of cytokines and bacterial metabolites.

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER

NCT06675656 - Predictive Role of Microbiome in Patients With Urothelial Carcinoma | Biotech Hunter | Biotech Hunter